Related Experiment Video
Updated: Apr 15, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis
Yen-Nien Liu1, JuanJuan Yin2, Ben Barrett2
1Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan liuy@tmu.edu.tw kellyka@mail.nih.gov.
Abstract:
Bone metastasis is the hallmark of progressive and castration-resistant prostate cancers. MicroRNA 1 (miR-1) levels are decreased in clinical samples of primary prostate cancer and further reduced in metastases. SRC has been implicated as a critical factor in bone metastasis, and here we show that SRC is a direct target of miR-1. In prostate cancer patient samples, miR-1 levels are inversely correlated with SRC expression and a SRC-dependent gene signature. Ectopic miR-1 expression inhibited extracellular signal-regulated kinase (ERK) signaling and bone metastasis in a xenograft model. In contrast, SRC overexpression was sufficient to reconstitute bone metastasis and ERK signaling in cells expressing high levels of miR-1. Androgen receptor (AR) activity, defined by an AR output signature, is low in a portion of castration-resistant prostate cancer. We show that AR binds to the miR-1-2 regulatory region and regulates miR-1 transcription. Patients with low miR-1 levels displayed correlated low canonical AR gene signatures. Our data support the existence of an AR-miR-1-SRC regulatory network. We propose that loss of miR-1 is one mechanistic link between low canonical AR output and SRC-promoted metastatic phenotypes.
Insights
Loss of microRNA 1 (miR-1) in prostate cancer promotes bone metastasis by increasing SRC expression. This regulatory network involves the androgen receptor (AR), linking low AR activity to cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Bone metastasis is a critical hallmark of advanced prostate cancer, particularly castration-resistant prostate cancer.
- Decreased levels of microRNA 1 (miR-1) are observed in primary prostate cancer and are further reduced in metastatic samples.
- SRC signaling is implicated in bone metastasis, but its precise regulation by microRNAs in this context is not fully understood.
Purpose of the Study:
- To elucidate the role of miR-1 in prostate cancer bone metastasis.
- To investigate the regulatory relationship between miR-1, SRC, and the androgen receptor (AR) in prostate cancer progression.
Main Methods:
- Analysis of clinical prostate cancer samples to correlate miR-1 levels with SRC expression and AR activity.
- In vitro studies using prostate cancer cell lines to assess the functional impact of miR-1 and SRC.
- Xenograft mouse models to evaluate the effect of miR-1 on bone metastasis and extracellular signal-regulated kinase (ERK) signaling.
Main Results:
- SRC was identified as a direct target of miR-1, with inverse correlation observed between miR-1 and SRC expression in patient samples.
- Ectopic miR-1 expression suppressed ERK signaling and bone metastasis in vivo.
- Androgen receptor (AR) directly binds to and regulates miR-1 transcription, with low miR-1 levels correlating with low AR gene signatures in patients.
Conclusions:
- A regulatory network involving AR, miR-1, and SRC is proposed to be crucial in prostate cancer bone metastasis.
- Loss of miR-1 represents a mechanistic link between reduced AR activity and SRC-driven metastatic phenotypes in castration-resistant prostate cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

